Side effects of mefloquine prophylaxis for malaria: An independent randomized controlled trial

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 91, Issue 2, 1997, Pages 199-203

  Croft, A M J ^a   Clayton, T C ^b   World, M J ^c  

^a MINISTRY OF DEFENCE   (United Kingdom)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c Royal Army Medical College   (United Kingdom)

Author keywords

Chemoprophylaxis; Chloroquine proguanil; Malaria; Mefloquine; Plasmodium spp; Side effects; Soldiers

Indexed keywords

ANTIMALARIAL AGENT; CHLOROQUINE; MEFLOQUINE; PROGUANIL;

AFRICA; ARMY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; GASTROINTESTINAL SYMPTOM; HUMAN; HUMAN EXPERIMENT; MALARIA; MALARIA CONTROL; MALE; NEUROPSYCHOLOGY; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PATIENT COMPLIANCE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; RISK; SOLDIER; SYMPTOM;

EID: 0030977804     PISSN: 00359203     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0035-9203(97)90223-6     Document Type: Article

References (25)

1. Anonymous (1993). Prevention of malaria in travellers from the United Kingdom. Communicable Disease Weekly Reports, 3, 99.
2. Barrett, P. J., Emmins, P. D., Clarke, P. D. & Bradley, D. J. (1996). Comparison of adverse events associated with use of mefloquine and combination of chloroquine and proguanil as antimalarial prophylaxis: postal and telephone survey of travellers. British Medical Journal, 313, 525-528.
3. Bern, J. L., Kerr, L. & Stuerchler, D. (1992). Mefloquine prophylaxis: an overview of spontaneous reports of severe psychiatric reactions and convulsions. Journal of Tropical Medicine and Hygiene, 95, 167-179.
4. Day, J. H. & Behrens, R. H. (1995). Delay in onset of malaria with mefloquine prophylaxis. Lancet, 345, 398.
5. Drysdale, S., Phillips-Howard, P. A. & Behrens, R. H. (1990). Proguanil, chloroquine, and mouth ulcers. Lancet, 335, 164.
6. Eriksson, B., Björkman, A. & Keisu, M. (1991). How safe is proguanil? A post-marketing investigation of side effects. Scandinavian Journal of Infectious Diseases, 23, 489-493.
7. Fish, D. R. & Espir, M. L. E. (1988). Convulsions associated with prophylactic antimalarial drugs: implications for people with epilepsy. British Medical Journal, 297, 526-527.
8. Hennequin, C., Boree, P. & Halfon, P. (1991). Agranulocytosis during treatment with mefloquine. Lancet, 337, 984.
9. Karbwang, J., Na-Bangchang, K., Thanavibul, A., Ditta-In, M. & Harinasuta, T. (1995). A comparative clinical trial of two different regimens of artemether plus mefloquine in multidrug resistant falciparum malaria. Transactions of the Royal Society of Tropical Medicine and Hygiene, 89, 296-298.
10. Lobel, H. O., Bernard, K. W., Williams, S. L., Hightower, A. W., Patchen, L. C. & Campbell, C. C. (1991). Effectiveness and tolerance of long-term malaria prophylaxis with mefloquine. Journal of the American Medical Association, 265, 361-364.
11. Lobel, H. O., Miani, M., Eng, T., Bernard, K. W., Hightower, A. W. & Campbell, C. C. (1993). Long-term malaria prophylaxis with weekly mefloquine. Lancet, 341, 848-851.
12. Looareesuwan, S., Viravan, C.,Vanijanonta, S., Wilairatana, P., Charoenlarp, P., Canfield, C. J. & Kyle, D. E. (1994). Randomized trial of mefloquine-doxycycline and artesunate-doxycycline for treatment of acute uncomplicated falciparum malaria. American Journal of Tropical Medicine and Hygiene, 50, 784-789.
13. Lovestone, S. (1991). Chloroquine induced mania. British Journal of Psychiatry, 159, 164-165.
14. Luxemburger, C., Nosten, F., ter Kuile, F., Frejacques, L., Chongsuphajaisiddhi, T. & White, N. J. (1991). Mefloquine for multidrug-resistant malaria. Lancet, 338, 1268.
15. Luxemburger, C., ter Kuile, F. O., Nosten, F., Dolan, G., Bradol, J. H., Phaipun, L., Chongsuphajaisiddhi,T. & White, N. J. (1994). Single day mefloquine-artesunate combination in the treatment of multi-drug resistant falciparum malaria. Transactions of the Royal Society of Tropical Medicine and Hygiene, 88, 213-217.
16. Nosten, F, ter Kuile, F. O., Luxemburger, C., Woodrow, C., Kyle, D. E., Chongsuphajaisiddhi,T. & White, N. J. (1993). Cardiac effects of antimalarial treatment with halofantrine. Lancet, 341, 1054-1056.
17. Perry, I. C. (1995). Malaria prophylaxis. British Medical Journal, 310, 1673.
18. Rouveix, B., Bricaire, F., Michon, C., Franssen, G., Lebras, J., Bernard, J., Ajana, F. & Vienne, J. L. (1989). Mefloquine and an acute brain syndrome. Annals of Internal Medicine, 110, 577-578.
19. Sowunmi, A., & Oduola, A. M. J. (1995). Open comparison of mefloquine, mefloquinc/sulfadoxine/pyrimethamine and chloroquine in acute uncomplicated falciparum malaria in children. Transactions of the Royal Society of Tropical Medicine and Hygiene, 89, 303-305.
20. Sowunmi, A., Salako, L. A., Oduola, A. M. J., Walker, O., Akindele, J. A. & Ogundahunsi, O. A. (1993). Neuropsychiatric side effects of mefloquine in Africans. Transactions of the Royal Society of Tropical Medicine and Hygiene, 87, 462-463.
21. Steffen, R., Fuchs, E., Schildknecht, J., Naef, U., Funk, M., Schlagenhauf, P., Philips-Howard, P., Nevill, C. & Stürchler, D. (1993). Mefloquine compared with other malaria chemoprophylactic regimens in tourists visiting East Africa. Lancet, 341, 1299-1303.
22. Ter Kuile, F. O., Dolan, G., Kosten, F., Edstein, M. D., Luxemberger, C., Phaipun, L., Chongsuphajaisiddhi, T., Webster, H. K. & White, N. J. (1993). Halofantrine versus mefloquine in treatment of multi-drug resistant falciparum malaria. Lancet, 341, 1044-1049.
23. Van den Enden, E., Van Grompel, A., Colebunders, R. & Van den Enden, J. (1991). Mefloquine induced Stevens-Johnson syndrome. Lancet, 337, 683.
24. Weinke, T., Trautmann, M., Heldt, T., Weber, G., Eichenlaub, D., Fleischer, K., Kern, W. & Pohle, H. D. (1991). Neuropsychiatric side effects after the use of mefloquine. American Journal of Tropical Medicine and Hygiene, 45, 86-91.
25. WHO [Malaria Unit] (1991). Review of central nervous system adverse events related to the antimalarial, mefloquine (1985-1990). Geneva: World Health Organization, mimeographed document WHO/MAL 91.1063.